Ann: Appendix 4C - quarterly, page-39

Do you know how many users the Omnitest would have and what sort of revenue it would produce @djwally? I agree with your comment that this is a company making announcement. B Braun have spent from what I can see over $500k on LSH engineering the Bodytel to complement their devices. The funds LSH were receiving for engineering services should be minimal in contrast to the SaaS management model and user subscription fees that they are moving to. From memory the deals with just B Braun and Beurer in Germany alone for diabetes and glucose monitoring was valued at $10Mil over 3 years, or $3Mil per year. LSH is operating in a high margin, low cost area of the Mhealth space. Revenues of just $2-3Mil per year would see the company profitable.